Entrar/Registro  
HOME SPANISH
 
Medicina Crítica
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Medicina Crítica >Year 2006, Issue 2


Morales MG, Ruiz ÁM, Aguirre SJ, Elizalde GJJ, Poblano MM, Martínez SJ
Procalcitonin for early diagnosis of bacterial sepsis
Rev Asoc Mex Med Crit y Ter Int 2006; 20 (2)

Language: Español
References: 18
Page: 57-64
PDF: 158.52 Kb.


Full text




ABSTRACT

Introduction: Procalcitonin (PCT) has been used as a marker of infection in the intensive care unit.
Objective: Early identification of SIRS patients with infection by determination of circulating plasma concentrations of procalcitonin.
Design: Prospective study.
Setting: ICU of a private tertiary care hospital of Mexico City.
Patients: Thirty patients divided in two groups: A) 16 SIRS patients (mean age 60.4 ± 21.2 yrs) and B) 14 sepsis patients (mean age 68.6 ± 14.8 yrs) admitted to ICU during a six-month period.
Measurements and main results: Circulating plasma concentrations of procalcitonin were determined at admission and at 24, 48, 72 hours and thereafter every 48 hours (a total of six determinations). Level of PCT at admission was 0.46 ug•dL in SIRS patients and 1.9 ug•dL in sepsis patients (p = 0.03). APACHE II Scale was 10.6 ± 6.3 vs 14.1 ± 7 points (p = NS), ICU stay 14.5 ± 15 vs 10.3 ± 5.8 days (p = NS) and mortality rate 6.3% vs 21.4%, respectively.
Conclusion: Procalcitonin is a useful marker to discriminate SIRS and sepsis in critically ill patients.


Key words: Procalcitonin, marker, sepsis, SIRS, discrimination, early diagnosis, critically ill patients.


REFERENCIAS

  1. Christ-Crains M, Müller B. Procalcitonin on the dusty way to the holy grail: A progress report. In Yearbook of intensive care and emergency medicine. Edited by Vicent JL. Berlin: Springer-Verlag; 2005:461-76.

  2. Becker KL, O´Neill WL, Snider R, Nylen E, Moore CF, Jeng J et al. Hyperprocalcitoninemia in inhalation burn injury: a response of the pulmonary neuroendrocrine cell? Anat Rec 1993;236:136-38.

  3. Angus D, Burgner D, Wunderink R, Mira JP, Gerlach H, Wiedermann CJ, Vincent JL. Meeting report. The PIRO Concept: P is for predisposition. Critical Care Forum 2003;7:248-51.

  4. Vincent JL, Opal S, Torres A, Boten M, Cohen J, Wunderink R. Meeting report. The PIRO concept: I is for infection. Critical Care Forum 2003;7(3):252-55.

  5. Gerlach H, Dhainaul JF, Harbarth S, Reinhart K, Marshall JC, Levy M. Meeting report. The PIRO concept: R is for response. Critical Care Forum 2003;7(3):256-59.

  6. Vicent JL, Wendon J, Groeneveld J, Marshall JC, Streat S, Carlet J. Meeting report. The PIRO concept: O is for organ dysfunction. Critical Care Forum 2003;7(3):260-264.

  7. Martin GS, Mannito DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.

  8. Assicot M, Gendrel D et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-18.

  9. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-56.

  10. Cohen J, Brun-Buisson C, Torres A, Jorgensen J. Diagnosis of infection in sepsis: An evidence- based review. Crit Care Med 2004;32:S466-S494.

  11. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-83.

  12. Ugarte H, Silva E, Mercan D, De Mendoza A, Vicent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504.

  13. Ruokonen E, Ilkka L, Niskanen M, Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002;46:398-404.

  14. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000;28:2793-98.

  15. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164: 396-402.

  16. Tugrul S, Esen F, Celebi S, Ozcan PE, Akinci O, Cakar N et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 2002;30:747-54.

  17. Balci C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Critical Care 2003;7:85-90.

  18. Bochud PY, Boten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review. Crit Care Med 2004;32:S495-S512.






>Journals >Medicina Crítica >Year 2006, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019